University Hospital Zurich, Department of Dermatology
Welcome,         Profile    Billing    Logout  
 13 Trials 
18 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dummer, Reinhard
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
Nov IIT- Pyrex, NCT04652258: Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy

Terminated
2
20
Europe
Actemra
University of Zurich
Pyrexia
10/21
10/21
NCT05529316: A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

Active, not recruiting
2
220
Europe, US, RoW
Botensilimab, AGEN1181, Balstilimab, AGEN2034
Agenus Inc.
Advanced Melanoma
05/28
05/28
DUNCAN, NCT04362722 / 2020-003299-42: Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients

Recruiting
2
40
Europe
L19IL2 +L19TNF, bifikafusp alfa + onfekafusp alfa
Philogen S.p.A., Philogen S.p.A.
Carcinoma, Basal Cell, Carcinoma, Cutaneous Squamous Cell
09/24
09/24
NCT04679480: Anti-PD1-antibody and Pulsed HHI for Advanced BCC

Active, not recruiting
2
20
Europe
Cemiplimab Injection [Libtayo], Sonidegib
Reinhard Dummer, Sanofi, Sun Pharmaceutical Industries Ltd
Basal Cell Carcinoma
12/24
12/24
NCT05120596: First in Human Study of T3P-Y058-739 (T3P)

Recruiting
1/2
100
Europe
Pembrolizumab+T3P-Y058-739, T3P-Y058-739 (IV), T3P-Y058-739 (IT)
T3 Pharmaceuticals AG
Advanced Solid Tumor
02/26
10/26
GDFATHER, NCT04725474 / 2020-002103-19: First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer

Active, not recruiting
1/2
274
Europe
visugromab (CTL-002)
CatalYm GmbH, CatalYm GmbH
Solid Tumor, Adult
10/25
10/27
SGNBB228-001, NCT05571839: A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Recruiting
1
275
Europe, Canada, US
PF-08046049
Seagen Inc.
Cutaneous Melanoma, Non-small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Neoplasms, Mesothelioma
11/26
11/27
Hofbauer, Günther
NCT01976468: Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"

Active, not recruiting
N/A
100
Europe
SCC metastasis
University of Zurich, Leiden University Medical Center
Squamous Cell Carcinoma
01/23
01/25
Hofbauer, Guenther
NCT02205593: Haut-Tief Patient Education on Psoriasis and Eczema

Active, not recruiting
N/A
80
Europe
Control
University of Zurich
Psoriasis, Atopic Dermatitis/ Eczema
10/18
12/22
Navarini, Alexander A
Neo-DREAM, NCT03567889 / 2021-003064-27: Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

Recruiting
3
186
Europe, US
Daromun, Surgery, Adjuvant therapy
Philogen S.p.A., Philogen S.p.A.
Melanoma Stage IIIB/C
06/24
06/26
NCT06319794: Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis

Recruiting
2
40
Europe
Bimiralisib
TORQUR
Actinic Keratosis
12/24
12/24
NCT05848453: Safety, Tolerability, and Pharmacokinetics of BAP5191 in Healthy Adults Following Topical Application of Repeat Doses

Completed
1
24
Europe
BAP5191
Bacoba AG, University Hospital, Basel, Switzerland, Swiss TPH, Basel, Switzerland
Healthy
03/24
03/24
AcneDect, NCT04060160: Acne Detection Software

Terminated
N/A
25
Europe
Self- learning software that can detect acne lesions, Patient reported outcomes
University Hospital, Basel, Switzerland
Acne Lesions, Acne Vulgaris
09/24
09/24
NCT04231500: The Skin Microbiome in Graft Versus Host Disease

Recruiting
N/A
60
Europe
Skin swabs, Skin punch biopsies, additional blood sampling
University Hospital, Basel, Switzerland, Gottfried und Julia Bangerter- Rhyner-Stiftung, Basel
Skin Microbiome, Graft Versus Host Disease, Graft Versus Host Disease in Skin
03/26
03/27
NEUTROSKIN, NCT05732987: Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Recruiting
N/A
3370
Europe
Analysis of samples
University Hospital, Basel, Switzerland
Neutrophil-mediated Inflammatory Dermatoses, Inflammatory Dermatoses
09/29
09/29
IRASPEN, NCT04359394: International Rare And Severe Psoriasis Expert Network

Recruiting
N/A
180
Europe, RoW
biological sampling, Phenotypic description, Photography
University Hospital, Basel, Switzerland, Boehringer Ingelheim
Pustular Psoriasis (PP)
12/30
12/30
SDNTT, NCT01706692: Swiss Dermatology Network of Targeted Therapies

Recruiting
N/A
1121
Europe
Adalimumab, Humira, Etanercept, Enbrel, Infliximab, Remicade, Ustekinumab, Stelara, Cyclosporine A, Fumaric acids, Methotrexate, Other anti-psoriatic systemic treatments
Swiss Dermatology Network for Targeted Therapies
Psoriasis
03/32
03/32
Mueller, Philipp
No trials found

Download Options